NPR Radio Host Has Ties to Drug Makers
Between 2000 and 2007, the psychiatrist who hosts National Public Radio's "The Infinite Mind" received at least $1.3 million giving lectures for drug makers, a connection that wasn't mentioned on the program.
In his shows, Dr. Frederick K. Goodwin often discussed topics linked to the commercial interests of the companies for which he consults, The New York Times reported. For example, in a Sept. 20, 2005, program he told his audience that untreated bipolar disorder in children could lead to brain damage, a controversial opinion. Goodwin then told his audience that "modern treatments -- mood stabilizers in particular -- have been proven both safe and effective in bipolar children," the newspaper said.
On the same day, drug maker GlaxoSmithKline paid Goodwin $2,500 to give a promotional lecture for a mood stabilizer drug. In 2005, Goodwin made more than $329,000 promoting that drug, the Times said.
National Public Radio wouldn't have aired Goodwin's program if his ties to drug companies were known, Margaret Low Smith, vice president of N.P.R., told the Times. She said "The Infinite Mind" will be removed from N.P.R.'s satellite service next week, the earliest possible date.
Reported by Nurse Tips - nursetips.blogspot.com/
A story published in HULIQ on NPR reporter Pharma ties says "NPR will be removing “The Infinite Mind” from its satellite radio service next week. NPR also indicated that had it been aware of Goodwin’s ties to Big Pharma, it would not have aired the program.
Dr. Frederick Goodwin has a list of impressive credentials: research professor of psychiatry at George Washington University, and also director of the Psychopharmacology Research Center and the Center on Neuroscience, Medical Progress, and Society at the George Washington University Medical Center.